We provide you with 20 years of free, institutional-grade data for LQDA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LQDA. Explore the full financial landscape of LQDA stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Eshelman Ventures, LLC | Sale | -17,364 | $3.13 | $54,349 | 2020-11-27 |
| Eshelman Ventures, LLC | Sale | -283,465 | $3.15 | $894,247 | 2020-11-25 |
| Eshelman Ventures, LLC | Sale | -133,346 | $3.16 | $421,347 | 2020-11-24 |
| Eshelman Ventures, LLC | Open Market Purchase | 1,875,000 | $8 | 2020-07-02 | |
| Maynor Benjamin | Sale | -2,577 | $9.06 | $23,348 | 2020-05-28 |
| Maynor Benjamin | Derivatives Exercise | 4,754 | 2020-05-28 | ||
| Maynor Benjamin | Sale | -3,319 | $6.23 | $20,677 | 2020-04-16 |
| Maynor Benjamin | Derivatives Exercise | 6,132 | 2020-04-16 | ||
| Eshelman Ventures, LLC | Open Market Purchase | 79,250 | $4.85 | 2020-04-07 | |
| Eshelman Ventures, LLC | Open Market Purchase | 52,223 | $4.89 | 2020-04-03 | |
| Eshelman Ventures, LLC | Open Market Purchase | 44,100 | $4.76 | 2020-04-01 | |
| Fowler Neal Franklin | Grant, award...etc | 30,400 | 2020-03-20 | ||
| Katz Richard D | Grant, award...etc | 10,833 | 2020-03-20 | ||
| Thomas Jeri | Grant, award...etc | 8,333 | 2020-03-20 | ||
| Maynor Benjamin | Grant, award...etc | 8,333 | 2020-03-20 | ||
| Roscigno Robert F | Grant, award...etc | 8,333 | 2020-03-20 | ||
| Lippe Robert A | Grant, award...etc | 10,833 | 2020-03-20 | ||
| Krawchick Florina | Grant, award...etc | 7,500 | 2020-03-20 | ||
| Bloch Stephen M | Grant, award...etc | 319,488 | $3.13 | 2020-01-10 | |
| Canaan VIII LP | Open Market Purchase | 319,488 | $3.13 | 2020-01-10 | |
| Eshelman Ventures, LLC | Initial | 2020-01-06 | |||
| Albury Timothy | Sale | -6,762 | $6 | $40,572 | 2019-08-26 |
| Albury Timothy | Derivatives Exercise | 8,199 | 2019-08-26 | ||
| Albury Timothy | Sale | -1,386 | $7.06 | $9,785 | 2019-08-15 |
| Albury Timothy | Derivatives Exercise | 2,001 | 2019-08-15 | ||
| Krawchick Florina | Initial | 2019-07-26 | |||
| SNYDERMAN RALPH | Derivatives Exercise | 5,494 | 2019-04-26 | ||
| Maynor Benjamin | Sale | -2,187 | $18.95 | $41,444 | 2019-03-01 |
| Maynor Benjamin | Derivatives Exercise | 2,187 | 2019-03-01 | ||
| GORDON KEVIN K | Sale | -943 | $15.83 | $14,928 | 2019-02-22 |
| GORDON KEVIN K | Sale | -11,322 | $14.14 | $160,093 | 2019-01-24 |
| Kirsch Arthur S | Open Market Purchase | 1,000 | $18 | 2018-11-15 | |
| Kirsch Arthur S | Open Market Purchase | 1,000 | $18.25 | 2018-11-13 | |
| GORDON KEVIN K | Grant, award...etc | 5,870 | 2018-10-16 | ||
| Fowler Neal Franklin | Grant, award...etc | 11,238 | 2018-10-16 | ||
| Albury Timothy | Sale | -2,157 | $19.46 | $41,975 | 2018-09-14 |
| Albury Timothy | Derivatives Exercise | 10,843 | 2018-09-14 | ||
| SANDELL SCOTT D | Open Market Purchase | 545,455 | $11 | 2018-08-01 | |
| KERINS PATRICK J | Open Market Purchase | 545,455 | $11 | 2018-08-01 | |
| BASKETT FOREST | Open Market Purchase | 545,455 | $11 | 2018-08-01 | |
| BARRIS PETER J | Open Market Purchase | 545,455 | $11 | 2018-08-01 |
The information provided in this report about LQDA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Liquidia Corporation(NASDAQ:LQDA) 
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include LIQ861, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension; ...
Website: http://www.liquidia.com
Founded: 2004
Full Time Employees: 64
Sector: Healthcare
Industry: Biotechnology